385 related articles for article (PubMed ID: 16585524)
1. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.
Loo YM; Owen DM; Li K; Erickson AK; Johnson CL; Fish PM; Carney DS; Wang T; Ishida H; Yoneyama M; Fujita T; Saito T; Lee WM; Hagedorn CH; Lau DT; Weinman SA; Lemon SM; Gale M
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):6001-6. PubMed ID: 16585524
[TBL] [Abstract][Full Text] [Related]
2. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
3. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
[TBL] [Abstract][Full Text] [Related]
5. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
[TBL] [Abstract][Full Text] [Related]
7. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus reveals a novel early control in acute immune response.
Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF
PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
Hiscott J; Lacoste J; Lin R
Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
[TBL] [Abstract][Full Text] [Related]
11. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
Horner SM; Park HS; Gale M
J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms.
Cheng G; Zhong J; Chisari FV
Proc Natl Acad Sci U S A; 2006 May; 103(22):8499-504. PubMed ID: 16707574
[TBL] [Abstract][Full Text] [Related]
14. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
15. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.
Mibayashi M; Martínez-Sobrido L; Loo YM; Cárdenas WB; Gale M; García-Sastre A
J Virol; 2007 Jan; 81(2):514-24. PubMed ID: 17079289
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
Binder M; Kochs G; Bartenschlager R; Lohmann V
Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus proteins interfere with the activation of chemokine gene promoters and downregulate chemokine gene expression.
Sillanpää M; Kaukinen P; Melén K; Julkunen I
J Gen Virol; 2008 Feb; 89(Pt 2):432-443. PubMed ID: 18198374
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
20. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
